期刊文献+

从脾胃论治2型糖尿病高脂血症临床研究 被引量:2

Clinical Research of Hyperlipidemia of Type 2 Diabetes Treated from the Spleen and Stomach
下载PDF
导出
摘要 目的:探讨从脾胃论治2型糖尿病高脂血症的临床疗效。方法:62例患者中病位在脾胃者为治疗组(26例),采用醒脾泄热法治疗。病位在其他脏腑者为对照组(36例),以益气养阴法治疗。两组均给予饮食、血糖控制、血脂康1/2量等基础治疗。治疗前后观察两组总胆固醇(TC)、三酰甘油(TG)变化。结果:对照组治疗后TC、TG无明显变化;治疗组治疗后TG明显降低,组间比较差异有统计学意义(P<0.05),TC指标无明显变化(P>0.05)。结论:从脾胃论治2型糖尿病高脂血症疗效显著。 Objective:To explore the clinical effect of hyperlipidemia of type 2 diabetes treated from the spleen and stomach.Methods:62 cases of patients were divided into the treatment group of 26 cases(spleen and stomach as the disease location) and the control group of 36 cases(other viscera as as the disease location).The two group were treated with awaking the spleen and reducing heat method and supplementing qi and nourishing yin method respectively.Foundation treatment such as diet,blood glucose control,and half dosage of xuezhikang were given of the two groups.The change of total cholesterol(TC) and three acyl glycerin(TG) in the two group before and after the treatment were observed.Results:After treatment,the change of TC and TG of the control group were not obvious;TG of the treatment group after treatment was significantly decreased,and comparison of TG between the two groups showed that the difference was statistically significant(P0.05) and TC index had no obvious change(P0.05).Conclusion:The effect of hyperlipicdemia of type 2 diabetes treated from the spleen and stomach is remarkable.
作者 丁煜 李伟
机构地区 南京江宁中医院
出处 《中医学报》 CAS 2013年第8期1213-1214,共2页 Acta Chinese Medicine
关键词 2型糖尿病 高脂血症 醒脾泄热法 益气养阴法 type 2 diabetes hyperlipidemia spleen stomach waking the spleen and reducing heat method supplementing qi and nourishing yin method
  • 相关文献

参考文献13

  • 1Guerre,M.M..Adip os etissu e horm on es[J].J Endocrinol lnvest,2002,25(10):855-861.
  • 2Mora,S.,Pessin,J.E..An adipocent ric view of sign alin g and intracellular t raff icking[J].Diabet es Met ab Res Rev,2002,18(5):345-356.
  • 3陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 4中华人民共和国卫生部.中药新药治疗消渴病(糖尿病)的临床研究指导原则[M].北京:中国医药科技出版社1993:215-218.
  • 5第五永长,许建秦.胰岛素抵抗中医病机探讨[J].四川中医,2008,26(1):8-11. 被引量:34
  • 6丁曦,姚定国.2型糖尿病肥胖患者血糖 胰岛素指标及中医辨证特征[J].中华中医药学刊,2010,28(9):1963-1964. 被引量:25
  • 7童奎骅,王兴华.117例2型糖尿病患者的中医辨证分析[J].浙江中医杂志,2012,47(2):113-114. 被引量:8
  • 8Birjmohun,R.S.,Hutten,B.A.,Kastelein,J.J.,et al.Efficacy andsafety of high-density lipoprotein cholesterol-increasing compounds:ameta-analysis of randomized controlled trials[J].J Am Coll Cardiol,2005,45(2):185-197.
  • 9Davidson,M.H.,Armani,A.,McKenney,J.M.,et al.Safety consid-erations with fibrate therapy[J].Am J Cardiol,2007,99(6):3-18.
  • 10Holoshitz,N.,Alsheikh-Ali,A.A.,Karas,R.H..Relative safety ofgemfibrozil and fenofibrate in the absence of concomitant cerivastatinuse[J].Am J Cardiol,2008,101(1):95-97.

二级参考文献31

共引文献1888

同被引文献11

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部